By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom said after the close of the market on Wednesday that it has filed a motion for a preliminary injunction against Aria Diagnostics.

Sequenom is seeking to stop Aria from making, using, selling, or offering for sale, importing, or exporting tests for detecting fetal chromosomal aneuploidy that Sequenom claims infringes on a patent it holds until pending litigation is resolved.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.